STOCKS OPEN LOWER WITH FED IN FOCUS, AMAZON EARNINGS ON DECK

Prospect of rate cuts has fallen dramatically since the start of 2024, helping drive up Treasury yields

ABBV Jan 2025 130.000 call

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

33.50

0.00

(0.00%)

As of 01:05PM EDT. Market open.

Loading interactive chart...

Insider Monkey
AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript April 26, 2024 AbbVie Inc. beats earnings expectations. Reported EPS is $2.31, expectations were $2.26. AbbVie Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and thank you for standing […]
Simply Wall St.
Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
AbbVie Inc. ( NYSE:ABBV ) investors will be delighted, with the company turning in some strong numbers with its latest...
Investor's Business Daily
AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
Fears that Humira biosimilars will erode AbbVie's topline are overblown, an analyst said Monday. He has an outperform rating on AbbVie stock.